A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk

DNA and Cell Biology

Volumn 30, Issue 11, 2011, Pages 937-945

  Cui, Yun ^a   Xue, Huiping ^a   Lin, Bing ^b   Ni, Peihua ^c   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW;

CADHERINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; STOMACH NEOPLASMS;

EID: 80655128302     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1257     Document Type: Article

References (35)

1. Al-Moundhri, M.S., Al-Khanbashi, M., Al-Kindi, M., Al-Nab-hani, M., Burney, I.A., Al-Farsi, A., and Al-Bahrani, B. (2010). Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol 16, 3432-3436.
2. Borges Bdo, N., Santos Eda, S., Bastos, C.E., Pinto, L.C., Ansel-mo, N.P., Quaresma, J.A., Calcagno, D.Q., Burbano, R.M., and Harada, M.L. (2010). Promoter polymorphisms and methyla-tion of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Anticancer Res 30, 2225-2233.
3. Bussemakers, M.J., van Moorselaar, R.J., Giroldi, L.A., Ichikawa, T., Isaacs, J.T., Takeichi, M., Debruyne, F.M., and Schalken, J.A. (1992). Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 52, 2916-2922.
4. Cao, W.J., Zhang, Z.Y., and Yue, Q.Y. (2010). CDH1 C-160A promoter polymorphism and genetic susceptibility to gastric cancer: a meta-analysis. Shi Jie Hua Ren xiao Hua Za Zhi 18, 1270-1274.
5. Camargo, M.C., Mera, R., Correa, P., Peek, R.M., Jr., Fontham, E.T., Goodman, K.J., Piazuelo, M.B., Sicinschi, L., Zabaleta, J., and Schneider, B.G. (2006). Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15, 1674-1687. (Pubitemid 44497104)
6. Christofori, G., and Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24, 73-76. (Pubitemid 29346577)
7. Corso, G., Berardi, A., Marrelli, D., Pedrazzani, C., Garosi, L., Pinto, E., and Roviello, F. (2009). CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev 18, 46-49.
8. Gao, L., Nieters, A., and Brenner, H. (2008). Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther 28, 565-573.
9. Grunwald, G.B. (1993). The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 5, 797-805.
10. Heidl, G., Langhans, P., Mellin, W., Bunte, H., and Grundmann, E. (1993). Adeno-carcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 120, 95-99. (Pubitemid 23314763)
11. Humar, B., Graziano, F., Cascinu, S., Catalano, V., Ruzzo, A.M., Magnani, M., Toro, T., Burchill, T., Futschik, M.E., Merriman, T., and Guilford, P. (2002). Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Onco-gene 21, 8192-8195. (Pubitemid 35454423)
12. Jenab, M., McKay, J.D., Ferrari, P., Biessy, C., Laing, S., Munar, G.M., Sala, N., Pena, S., Crusius, J.B., Overvad, K., Jensen, M.K., Olsen, A., Tjonneland, A., Clavel-Chapelon, F., Boutron-Ruault, M.C., Kaaks, R., Linseisen, J., Boeing, H., Bergmann, M.M., Trichopoulou, A., Georgila, C., Psaltopoulou, T., Mattiello, A., Vineis, P., Pala, V., Palli, D., Tumino, R., Numans, M.E., Peeters, P.H., Bueno-de-Mesquita, H.B., Lund, E., Ar-danaz, E., Sánchez, M.J., Dorronsoro, M., Sanchez, C.N., Quirós, J.R., Hallmans, G., Stenling, R., Manjer, J., Régner, S., Key, T., Bingham, S., Khaw, K.T., Slimani, N., Rinaldi, S., Boffetta, P., Carneiro, F., Riboli, E., and Gonzalez, C. (2008). CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 44, 774-780.
13. Kim, M.A., Lee, H.S., Yang, H.K., and Kim, W.H. (2005). Clin-icopathologic and protein expression differences be-tweencardia carcinoma and noncardia carcinoma of the stomach. Cancer 103, 1439-1446. (Pubitemid 40410741)
14. Kuraoka, K., Oue, N., Yokozaki, H., Kitadai, Y., Ito, R., Na-kayama, H., and Yasui, W. (2003). Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 23, 421-427.
15. Li, L.C., Chui, R.M., Sasaki, M., Nakajima, K., Perinchery, G., Au, H.C., Nojima, D., Carroll, P., and Dahiya, R. (2000). A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60, 873-876. (Pubitemid 30129518)
16. Loh, M., Koh, K.X., Yeo, B.H., Song, C.M., Chia, K.S., Zhu, F., Yeoh, K.G., Hill, J., Iacopetta, B., and Soong, R. (2009). Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 45, 2562-2568.
17. Lu, Y., Xu, Y.C., Shen, J., Yu, R.B., Niu, J.Y., Guo, J.T., Hu, X., and Shen, H.B. (2005). E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 11, 56-60. (Pubitemid 40090136)
18. Medina-Franco, H., Ramos-De la Medina, A., Vizcaino, G., and Medina-Franco, J.L. (2007). Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol 14, 2246-2249. (Pubitemid 47174898)
19. Park, W.S., Cho, Y.G., Park, J.Y., Kim, C.J., Lee, J.H., Kim, H.S., Lee, J.W., Song, Y.H., Park, C.H., Park, Y.K., Kim, S.Y., Nam, S.W., Lee, S.H., Yoo, N.J., and Lee, J.Y. (2003). A single nu-cleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 18, 501-504. (Pubitemid 38030516)
20. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108. (Pubitemid 40372904)
21. Perl, A.K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193. (Pubitemid 28162793)
22. Pharoah, P.D., Oliveira, C., Machado, J.C., Keller, G., Vogelsang, H., Laux, H., Becker, K.F., Hahn, H., Paproski, S.M., Brown, L.A., Caldas, C., and Huntsman, D. (2002). CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer 101, 196-197. (Pubitemid 34970913)
23. Saito, H., Fukumoto, Y., Osaki, T., Fukuda, K., Tatebe, S., Tsu-jitani, S., and Ikeguchi, M. (2006). Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 30, 1864-1869. (Pubitemid 44455000)
24. Song, C.G., Huang, C.M., Liu, X., Lu, H.S., Zhang, X.F., and Huang, W. (2005). Association of-160(C-A) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22, 557-559. (Pubitemid 41499219)
25. Suerbaum, S., and Michetti, P. (2002). Helicobacter pylori infection. N Engl J Med 347, 1175-1186.
26. Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T.F., Helms, P.J., Hakonarson, H., Halpi, E., Navon, R., and Attia, J. (2005a). Systematic review and metaanalysis of the association between{h}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162, 201-211. (Pubitemid 41373524)
27. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., and Attia, J. (2005b). A method for meta-analysis of molecular association studies. Stat Med 24, 1291-1306. (Pubitemid 40585169)
28. Wang, G.Y., Lu, C.Q., Zhang, R.M., Hu, X.H., and Luo, Z.W. (2008). The E-cadherin gene polymorphism 160C-A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 167, 7-14.
29. Wu, M.S., Huang, S.P., Chang, Y.T., Lin, M.T., Shun, C.T., Chang, M.C., Wang, H.P., Chen, C.J., and Lin, J.T. (2002). Association of the-160 C-a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94, 1443-1448.
30. Xue, H., Lin, B., Ni, P., Xu, H., and Huang, G. (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol 25, 1604-1617.
31. Xue, H., Ni, P., Lin, B., Xu, H., and Huang, G. (2011). X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Gastric Cancer Risk: A HuGE Review and Meta-Analysis. Am J Epidemiol 173, 363-375.
32. Yamada, H., Shinmura, K., Ikeda, S., Tao, H., Otani, T., Hanaoka, T., Tsuneyoshi, T., Tsugane, S., and Sugimura, H. (2007). Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 42, 1479-1485. (Pubitemid 350125545)
33. Yang, L. (2006). Incidence and mortality of gastric cancer in China. World J Gastroenterol 12, 17-20. (Pubitemid 43126077)
34. Zhang, B., Pan, K., Liu, Z., Zhou, J., Gu, L., Ji, J., Ma, J., You, W.C., and Deng, D. (2008a). Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol Biomarkers Prev 17, 2402-2408.
35. Zhang, X.F., Wang, Y.M., Ge, H., Cao, Y.Y., Chen, Z.F., Wen, D.G., Guo, W., Wang, N., Li, Y., and Zhang, J.H. (2008b). Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 21, 21-29.